Ultragenyx says Angelman therapy is working, but safety questions remain:
https://www.biopharmadive.com/news/ultragenyx-angelman-gtx-102-interim-results/713169/
- Forums
- ASX - By Stock
- NEU
- Ann: Completion of enrolment in Neuren's Angelman P2 trial
Ann: Completion of enrolment in Neuren's Angelman P2 trial, page-45
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$13.70 |
Change
-0.370(2.63%) |
Mkt cap ! $1.746B |
Open | High | Low | Value | Volume |
$13.73 | $13.88 | $13.40 | $4.396M | 320.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 312 | $13.70 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.72 | 546 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 317 | 13.610 |
7 | 900 | 13.600 |
6 | 1019 | 13.590 |
8 | 523 | 13.580 |
3 | 436 | 13.570 |
Price($) | Vol. | No. |
---|---|---|
13.620 | 251 | 10 |
13.630 | 465 | 5 |
13.640 | 423 | 4 |
13.650 | 401 | 5 |
13.660 | 907 | 6 |
Last trade - 12.14pm 04/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |